| COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. | ![]() |
University of Cambridge > Talks.cam > Accelerate Lunchtime Seminar Series > From Code to the Lab: Applying Transfer Learning to Discover New Antibacterials
From Code to the Lab: Applying Transfer Learning to Discover New AntibacterialsAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Sam Nallaperuma-Herzberg. The scarcity of high-quality public data presents a major hurdle for applying deep learning to drug discovery. This is particularly acute in the search for new antibiotics, where active compounds are rare. In this talk, I will discuss how my group has addressed this “low-data” challenge by applying transfer learning with deep graph neural networks (DGNNs) to discover novel antibacterials. By pre-training models on large, general chemical datasets before fine-tuning them on small, specific antibacterial screens, we were able to virtually screen over a billion compounds. Supported by a £15,000 grant from the Accelerate Programme, this computational work led to the experimental validation of several potent, low-toxicity compounds with broad-spectrum activity against critical ESKAPE pathogens, achieving a ~54% hit rate from our prioritized candidates. This project highlights a broader story about bridging the gap between computational theory and experimental practice. I’ll touch upon the significant challenges in developing robust benchmarks for molecular machine learning, a critical step for ensuring our models are truly learning meaningful chemical principles. Furthermore, I will share how our group, based in the maths faculty, collaborated with experimental facilities to validate our computational hypotheses, turning predictive models into tangible results. My goal is to encourage others in the Cambridge AI community to develop methodologies that are not only computationally novel but are also geared towards practical, hypothesis-driven validation, demonstrating how even modest funding can generate significant real-world impact. This talk is part of the Accelerate Lunchtime Seminar Series series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsCCIMI Short course: First-order methods for large scale optimisation problems Brain Mapping Unit Networks Meeting and the Cambridge Connectome Consortium Cambridge University Self-Build SocietyOther talksRothschild Public Lecture: Two cultures separated by a common language Nasal Mucosal Leishmaniasis: Clinical Features, Gaps in Models, and a New Experimental Direction? Artificial Intelligence in Radiotherapy Sense and Sensibility in Cognition: Unraveling the Neural Basis of Emotional Regulation Novel approaches to simulating the observable Universe Panel Discussion with Speakers |